Pharmaceuticals Stocks

Biogen Inc Valuation – February 2016 Update $BIIB

Biogen Inc does not qualify for either the Enterprising Investor or the more conservative Defensive Investor. The Defensive Investor is concerned with the lack of dividends along with the high PB ratio. The Enterprising Investor is concerned by the level of debt relative to the net current assets along with the lack of dividends.

Read More
Feature Value Investing Weekly

13 Best Stocks For Value Investors This Week – 10/17/15

We evaluated 25 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation model based on Benjamin Graham’s value investing formulas in order to determine an intrinsic value for each. Out of those 25 companies, only 13 were found to be undervalued or fairly valued and suitable for either Defensive or Enterprising Investors.

Read More
Feature Industry Review Pharmaceuticals

The Best Companies of the Pharmaceuticals Industry – August 2015

While ModernGraham supports the bottom-up approach to investing, many investors do utilize the top-down method, whereby an industry is selected before the company itself. With that in mind, this article will take a brief look at the best companies of the pharmaceuticals industry, selecting the most promising investment opportunities within the industry, and giving a broad look into the industry as a whole.

Read More
Back To Top